In addition to providing clinical interpretation of diagnostic assays, the Molecular Pathologist will oversee the development, validation, implementation, and quality management of molecular diagnostic testing, including next-generation sequencing (NGS)-based exome, genome, and targeted panel assays, as well as emerging molecular and genomic technologies. We deliver care across six states through two freestanding children's hospitals - Nemours Children's Hospital, Delaware and Nemours Children's Hospital, Florida - along with a network of more than 80 primary, urgent, and specialty care practices and more than 40 hospital partnerships.